Start-Up Previews (11/01)
Executive Summary
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Natural Products: Providing Diversity or Drug Candidates?, features profiles of Cerylid Biosciences Ltd., Evolutec Ltd. and Panacos Pharmaceuticals Inc.. Plus these Selected Start-Ups across Health Care: Bio IT Ltd., Colbar R&D Ltd., GW Pharmaceuticals PLC, High Throughput Genomics Inc. and UltraGuide Inc.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.